Mexico and Brazil do not plan on limiting access to AstraZeneca’s COVID-19 vaccine after the United Kingdom’s drug regulator recommended doing so amid a potential risk of blood clots.
Posted by UE editors
Click to copy the Short Url to this post: 
The Whole Web on a Single Page, for People Who Love Good Reads. Join Now →